Brasil
| Artículos de revistas
Bone density among long-term users of medroxyprogesterone acetate as a contraceptive
Registro en:
Contraception. Elsevier Science Inc, v. 58, n. 6, n. 351, n. 355, 1998.
0010-7824
WOS:000078719600004
Autor
Paiva, LC
Pinto-Neto, AM
Faundes, A
Institución
Resumen
The bone density (BD) of 72 women using depot-medroxyprogesterone acetate (DMPA) for at least 1 year was compared with that of 64 women who were not users of hormonal contraceptives. The ED of lumbar spine, femoral neck, Ward's triangle, and trochanter was measured by dual energy X-ray absorptiometry (DEXA-LUNAR DPX). Estradiol (E-2) concentrations were measured by radioimmunoassay (RIA). The mean age of DMPA users and nonusers was 31.8 and 31.1 years, respectively. Mean E-2 was 55.7 pg/mL for users and 149.9 pg/mL for controls (p < 0.001). The ED was significantly lower for DMPA users than for controls in all sites (p < 0.01). In addition, young adult T-scores in the lumbar spine were significantly lower among DMPA users than in controls (p < 0.01). Differences were maintained in a subsample of 47 women per group, paired by age and body mass index (BMI). Multiple regression analysis showed that older age, lower BMI, and longer amenorrhea were associated with lower ED in the femoral neck, whereas lower BMI and use of DMPA were associated with lower BD in the lumbar spine. (C) 1998 Elsevier Science Inc. All rights reserved. 58 6 351 355